Medical toxo (cardiovascular)DONE Flashcards

1
Q

uses of Beta Adrenergic Blockers & Calcium Channel Blockers

A

Hypertension, ischemic heart disease, congestive heart failure, and certain arrhythmias.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Moderate lipid soluble BB

A

Labetalol and Pindolol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

high lipid soluble BB

A

Propranolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Low lipid soluble BB

A

Atenolol and Sotalol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

.Non-dihydropyridine agents.

non DHB

A

Verapamil, and Diltiazem.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

moa of CCB

A

Inhibit Ca+, entry through calcium channels
located on
- Vascular smooth muscle
- Cardiac myocytes
- Cardiac nodal tissue (SA & AV nodes).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CVS manifestations of BB and CCB

A

a- Two cardinal signs: Hypotension and bradycardia.
b-A prolonged PR interval is an early sign
c- Prolongation of QRS interval may occur (in Propranolol).
d-Prolonged QT intervals, ventricular arrhythmia & Torsade’s de pointes may occur (in Sotalol & Bepridil).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Prolongation of QRS interval in

A

propranololarge dose of diphenhydramine
phenothiazine
TCA
Cocaine
Propranololl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

block sodium channel

A

large dose of diphenhydramine
phenothiazine
TCA
Cocaine
Propranolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

other manifestations of BB and CCB

A

a- CNS manifestations: seizures and coma.
b- Respiratory: pulmonary edema (due to anoxia as a result of hypotension).
c- Metabolic acidosis
d-Hyperglycemia (in CCBs only): due to suppression of insulin release coupled with body insulin resistance.
e- Hypoglycemia (in BBs only).
f- Hyperkalemia (in BBs only).
g- Bronchospasm occurs only in susceptible patients (in BBs only).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

investigations of BB and CCB

A

Blood glucose: decreased (in BBs) & increased in CCBs
electrolytes increased K in BBs
ABG
toxicological screening
ECG & cardiac monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment of BB and CCB toxicity

A

ABC
- Gastric Lavage.
- Activated charcoal
- Multiple dose activated charcoal (MDAC) is indicated in sustained-release pills.
- Whole-bowel irrigation (WBI) is indicated in sustained-release pills.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

antidotes of CCB

A

Calcium chloride
Calcium Gluconate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

treat bradycardia result from BB and CCb toxicity

A

Atropine 0.5 mg IV if no response:
Glucagon IV (In BBs toxicity only)
Norepinephrine continuous infusion.
cardiac pacing or intra aortic ballon pumps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hyperinsulinemic euglycemic therapy (HIET). is indicated in

A

BB and CCb toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

specific treatment of BB and CCB

A

Maintenance of hemodynamic stability d65 s90
Treat bradycardia
ii. Hyperinsulinemic euglycemic therapy (HIET).
iii. Intravenous lipid emulsion.

16
Q

Intravenous lipid emulsion is indicated in

A

BB and CCB toxicity

17
Q

moa of digoxin

A

Slows conduction through the atrioventricular (AV) node.

-It inhibits Na”—Ka” ATPase in the cardiac muscle fibers&raquo_space; increased intracellular Na* and Ca‘ and increased extracellular Ka”.

18
Q

uses of digoxin

A

treatment of congestive heart disease and cardiac arrhythmias.

19
Q

clinical presentation of digoxin toxicity

A

Tachyarrhythmias
Bradyarrhythmias
Hypotension
GIT: nausea, vomiting, colic and diarrhea.
Visual: blurring, halos (yellow / green halos).
CNS: headache, drowsiness, and disorientation.
Hyperkalemia in acute toxicity and hypokalemia in chronic patients

20
Q

causes blurring and blue green halos

A

Digoxin

21
Q

first manifestation to occur in digoxin toxicity

A

IT: (the first to occur) nausea, vomiting, colic and diarrhea.

22
Q

investigations of digoxin toxicicty

A

Hyperkalemia in acute toxicity
- Hypokalemia in chronic toxicity.
-Kidney function tests: (renal impairment alters elimination of digoxin).
- Serum caicium levels
- toxicological screening 10 (serious prognosis)

23
Q

treatment of digoxin

A

GIT contamination: GL, AC, MDAC
antidote: Digi-bind [Fab]
symptomatic: treatment of arrhythmias and hypokalemia
hyperkalemia: insulin in 5% glucose
avoid the use of calcium as it may increase digitalis toxicity

24
Q

antibody of digoxin

A

Digi-bind [Fab] (Digoxin-specific antibody fragments)

25
Q

indication of digi bind fab

A

acute ingestion >10 in adults, >4 in childeren
serum digoxin level >10 in adults, > in children
serum hyperkalemia (>5)
life threating arrhythmias: asystole, ventricular fibrillation or complete heart block.
end-organ damage (e.g., renal failure, altered mental status)